Straumann Holding AG (SAUHF)
USD 119.96
(0.3%)
USD 119.96
(0.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 246.07 Million CHF | -43.4% |
| 2022 | 434.78 Million CHF | 9.77% |
| 2021 | 396.07 Million CHF | 333.91% |
| 2020 | 91.28 Million CHF | -70.22% |
| 2019 | 306.47 Million CHF | 12.36% |
| 2018 | 272.77 Million CHF | -0.05% |
| 2017 | 272.91 Million CHF | 18.87% |
| 2016 | 229.6 Million CHF | 224.85% |
| 2015 | 70.67 Million CHF | -55.22% |
| 2014 | 157.82 Million CHF | 55.95% |
| 2013 | 101.2 Million CHF | 177.73% |
| 2012 | 36.43 Million CHF | -48.64% |
| 2011 | 70.95 Million CHF | -45.87% |
| 2010 | 131.08 Million CHF | -10.45% |
| 2009 | 146.37 Million CHF | 1693.13% |
| 2008 | 8.16 Million CHF | -95.36% |
| 2007 | 175.86 Million CHF | 24.09% |
| 2006 | 141.72 Million CHF | 10.84% |
| 2005 | 127.86 Million CHF | 27.93% |
| 2004 | 99.94 Million CHF | 24.47% |
| 2003 | 80.29 Million CHF | 43.46% |
| 2002 | 55.97 Million CHF | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 230.37 Million CHF | 471.7% |
| 2023 Q4 | 40.29 Million CHF | -80.42% |
| 2023 FY | 246.07 Million CHF | -43.4% |
| 2023 Q2 | 205.77 Million CHF | 21.48% |
| 2022 FY | 434.78 Million CHF | 9.77% |
| 2022 Q2 | 265.4 Million CHF | 18.89% |
| 2022 Q4 | 169.38 Million CHF | -36.18% |
| 2021 Q4 | 223.24 Million CHF | 29.16% |
| 2021 Q2 | 172.83 Million CHF | -6.44% |
| 2021 FY | 396.07 Million CHF | 333.91% |
| 2020 FY | 91.28 Million CHF | -70.22% |
| 2020 Q4 | 184.74 Million CHF | 297.67% |
| 2020 Q2 | -93.46 Million CHF | -158.19% |
| 2019 Q4 | 160.61 Million CHF | 10.12% |
| 2019 FY | 306.47 Million CHF | 12.36% |
| 2019 Q2 | 145.85 Million CHF | 1.94% |
| 2018 Q2 | 129.68 Million CHF | -7.05% |
| 2018 FY | 272.77 Million CHF | -0.05% |
| 2018 Q4 | 143.08 Million CHF | 10.33% |
| 2017 FY | 272.91 Million CHF | 18.87% |
| 2017 Q2 | 140.01 Million CHF | 47.88% |
| 2017 Q4 | 139.52 Million CHF | -0.35% |
| 2016 Q2 | 134.91 Million CHF | 86.9% |
| 2016 FY | 229.6 Million CHF | 224.85% |
| 2016 Q4 | 94.68 Million CHF | -29.82% |
| 2015 FY | 70.67 Million CHF | -55.22% |
| 2015 Q4 | 72.18 Million CHF | 4890.05% |
| 2015 Q2 | -1.5 Million CHF | -101.69% |
| 2014 Q2 | 68.73 Million CHF | 44.66% |
| 2014 Q4 | 89.09 Million CHF | 29.61% |
| 2014 FY | 157.82 Million CHF | 55.95% |
| 2013 Q4 | 47.51 Million CHF | -11.49% |
| 2013 Q2 | 53.68 Million CHF | 0.0% |
| 2013 FY | 101.2 Million CHF | 177.73% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | 36.43 Million CHF | -48.64% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 70.95 Million CHF | -45.87% |
| 2010 Q4 | - CHF | 0.0% |
| 2010 FY | 131.08 Million CHF | -10.45% |
| 2009 FY | 146.37 Million CHF | 1693.13% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | 8.16 Million CHF | -95.36% |
| 2007 FY | 175.86 Million CHF | 24.09% |
| 2006 FY | 141.72 Million CHF | 10.84% |
| 2005 FY | 127.86 Million CHF | 27.93% |
| 2004 FY | 99.94 Million CHF | 24.47% |
| 2003 FY | 80.29 Million CHF | 43.46% |
| 2002 FY | 55.97 Million CHF | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 26648.048% |
| Ansell Limited | 76.5 Million USD | -221.663% |
| Ansell Limited | 76.5 Million USD | -221.663% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -913.468% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 15194.191% |
| Psykey, Inc. | -1.32 Million USD | 18686.186% |
| ConvaTec Group Plc | 130.3 Million USD | -88.85% |
| ConvaTec Group Plc | 130.3 Million USD | -88.85% |
| Encision Inc. | -691.78 Thousand USD | 35670.692% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 173621.095% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 105094.752% |
| Innovative MedTech Inc. | -7.93 Million USD | 3199.574% |
| LifePoint, Inc. | -15.23 Million USD | 1715.536% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 3712.862% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 52013.924% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 89761.354% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 53707.187% |
| SmileDirectClub, Inc. | -86.4 Million USD | 384.792% |
| Sector 10, Inc. | 7036.00 USD | -3497228.027% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 87.708% |
| SheerVision, Inc. | -71.37 Thousand USD | 344854.539% |
| United Health Products, Inc. | -2.62 Million USD | 9480.364% |
| Vasamed, Inc. | -4.88 Million USD | 5134.049% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 10402.508% |
| Yubo International Biotech Limited | -1.2 Million USD | 20524.896% |